María Alejandra Medina

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

Zara Izadi, Erica J. Brenner, Satveer K. Mahil et al. · JAMA Network Open · 2021 · 116 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

Sebastian E. Sattui, Richard Conway, Michael Putman et al. · The Lancet Rheumatology · 2021 · 51 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

Primary Sjögren’s syndrome: Extraglandular manifestations and hydroxychloroquine therapy

Julia Demarchi, Sílvia Papasidero, María Alejandra Medina et al. · Clinical Rheumatology · 2017 · 48 citations

Medicine, Immunology, Internal Medicine +12

Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry

C. A. Isnardi, Karen Roberts, Verónica Saurit et al. · Clinical Rheumatology · 2022 · 21 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +10

Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study

Zara Izadi, Milena Gianfrancesco, Gabriela Schmajuk et al. · The Lancet Rheumatology · 2022 · 19 citations · Full text

Public Health, Health Sciences, Infectious Diseases +11